Conference Information
Winter Updates in Hematology Conference
Sacramento, California
February 13, 2027
Conference Description
The Winter Updates in Hematology Conference is a comprehensive educational program designed to provide healthcare professionals with timely updates from the most recent meetings on the latest advances in the diagnosis, treatment, and management of hematologic disorders. The conference will bring together hematology and oncology experts to discuss emerging therapies, evolving treatment standards, focusing on recent clinical trial data, and their practical application to patient care.
Through expert-led presentations and interactive dialogue, participants will explore developments across a range of hematologic malignancies. The program will emphasize the translation of new evidence into clinical practice, with a focus on optimizing treatment decisions, managing treatment-related challenges, and improving patient outcomes.
Through expert-led presentations, evidence-based clinical case discussions, and interactive learning, participants will explore developments across a range of hematologic malignancies and disorders. The program will examine recent clinical trial findings, evolving standards of care, emerging therapies, and practical approaches to managing hematologic diseases. Educational content will address targeted agents, immunotherapies, cellular therapies, supportive care, treatment-related toxicities, and other developments relevant to contemporary practice.
Target Audience
The Winter Updates in Hematology Conference is intended for healthcare professionals involved in the care of patients with hematologic disorders and malignancies, including:
- Hematologists and medical oncologists
- Hematology/oncology fellows and trainees
- Advanced practice providers, including nurse practitioners and physician assistants
- Oncology and hematology nurses
- Pharmacists
- Other healthcare professionals involved in the diagnosis, treatment, and supportive care of patients with hematologic diseases
Learner Objectives
At the conclusion of this conference, participants should be able to:
- Review recent advances and emerging evidence in the diagnosis and treatment of hematologic disorders and malignancies.
- Evaluate new clinical trial data and evolving standards of care that may influence the management of patients with hematologic diseases.
- Apply current evidence-based strategies to individualize treatment selection based on disease characteristics, patient factors, and treatment goals.
- Identify emerging and novel therapeutic approaches, including targeted therapies, immunotherapies, cellular therapies, and other innovative treatment strategies.
- Discuss strategies for recognizing and managing treatment-related adverse events and complications associated with contemporary hematologic therapies.
- Incorporate current clinical evidence and expert recommendations into everyday practice to optimize patient care and outcomes.
- Identify opportunities for multidisciplinary collaboration in the management of patients with complex hematologic conditions.